Bionomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 139.3%.

Top 16 shareholders own 21.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.88%	Armistice Capital LLC	1,733,773	€468.3k	8.84%	0.01%
5.25%	Apeiron Investment Group	1,024,309	€276.7k	0.68%	0.35%
2.81%	Lynx1 Capital Management LP	549,673	€148.5k	-8.34%	0.06%
2.66%	Presight Capital	518,717	€140.1k	-34.4%	1.28%
1.62%	Point72 Asset Management, L.P.	316,000	€85.4k	0%	no data
0.17%	Susquehanna International Group, LLP, Asset Management Arm	34,138	€9.2k	0%	no data
0.17%	Spyridon Papapetropoulos	33,599	€9.1k	0%	no data
0.043%	Rhumbline Advisers Ltd Partnership	8,300	€2.2k	278%	no data
0.0077%	Peter Miles Davies	1,511	€408.3	0%	no data
0.0072%	David Wilson	1,410	€380.8	0%	no data
0.0046%	Morgan Stanley, Investment Banking and Brokerage Investments	894	€241.6	12.6%	no data
0.0037%	Elizabeth Doolin	714	€193.1	0%	no data
0.0029%	Alan Fisher	560	€151.4	0%	no data
0.0015%	Northwestern Mutual Wealth Management Company	303	€81.8	0%	no data
0.001%	Aspire Private Capital, LLC	200	€53.8	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€0.5	0%	no data